IMUX

Immunic, Inc. - Common Stock (IMUX)

About Immunic, Inc. - Common Stock (IMUX)

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. The firm’s products include IMU-838, IMU-935, and IMU-856. The company was founded in May 2003 and is headquartered in New York, NY.

Details

Daily high

$11.07

Daily low

$10.68

Price at open

$10.86

52 Week High

$17.43

52 Week Low

$5.06

Market cap

144.9M

Dividend yield

Volume

113,310

Avg. volume

321,939

P/E ratio

-2.21

Immunic, Inc. - Common Stock News